Controlling the price of medicine by restricting overseas sales may lead to reduced availability of medicines. Allowing the market to regulate healthcare costs could significantly lower expenses. The healthcare system is not entirely free market as many costs are covered by the federal government, especially in end-of-life care. This contrasts with consumer goods like televisions, which are subject to market forces and not government subsidies.